Work

Research Priorities for Precision Medicine in NAFLD

Year: 2023
Type: article
Abstract: Key points • Despite its enormous burden and impact, NAFLD has received little public health attention globally, with weak and fragmented responses. • Population-based screening is not considered cost-effective, but several studies and expert guidelines suggest that individuals with diabetes and other metabolic risk factors, such as obesity, should be considered for case-finding strategies. • NAFLD's heterogeneity represents a major challenge in developing highly effective therapies. The identification of NAFLD
Authors: Paula Iruzubieta, Ramon Bataller, María Teresa Arias-Loste, Marco Arrese, José Luis Calleja, Graciela Castro-Narro, Kenneth Cusi, John F. Dillon, María Luz Martínez-Chantar, Miguel Mateo, Antonio Pérez, Mary E. Rinella, Manuel Romero-Gómez, Jörn M. Schattenberg, Shira Zelber-Sagi, Javier Crespo, Jeffrey V. Lazarus
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: green
OpenAlex ID: W6948661957
FWCI:
Cites:
Cited by:
Related to: 10